Troilus Gold is a Canadian based development stage resource company focused on the potential restart and mineral expansion of the former producing Troilus gold and copper mine, located within the Frotêt-Evans Greenstone Belt in Quebec.
Troilus Gold is a Canadian based development stage resource company focused on the potential restart and mineral expansion of the former producing Troilus gold and copper mine, located within the Frotêt-Evans Greenstone Belt in Quebec.
Eastmain Resources
Post in 2018
Eastmain Resources Inc. is a Canadian exploration-stage company focused on acquiring and exploring metallic mineral resource properties, primarily gold, in Ontario and Québec. Established in 1982 and headquartered in Toronto, the company’s flagship project is the Clearwater project in the James Bay region of Québec. Eastmain also holds interests in several other projects, including the Eastmain Mine, Eleonore South Joint Venture, and Lac Lessard, among others. The company emphasizes aggressive exploration for world-class ore deposits and has formed joint ventures and strategic alliances with prominent mining companies to leverage their financial resources and expertise. This approach aims to enhance the company's market share and project advancement in one of the world's most mineral-rich and politically stable regions. As of October 2020, Eastmain operates as a subsidiary of Fury Gold Mines Limited.
Troilus Gold is a Canadian based development stage resource company focused on the potential restart and mineral expansion of the former producing Troilus gold and copper mine, located within the Frotêt-Evans Greenstone Belt in Quebec.
Troilus Gold is a Canadian based development stage resource company focused on the potential restart and mineral expansion of the former producing Troilus gold and copper mine, located within the Frotêt-Evans Greenstone Belt in Quebec.
Integra Resources
Post in 2017
Integra Resources Corp. is a development-stage company based in Vancouver, Canada, focused on the acquisition, exploration, and development of mineral properties primarily in the Americas. The company is centered on its flagship DeLamar project, which includes gold and silver deposits in southwestern Idaho. Additionally, Integra holds an option agreement for the War Eagle Gold-Silver Deposit and has interests in various exploration properties in Ontario and Quebec, Canada. The company is also advancing the Nevada North Project, which encompasses the Wildcat and Mountain View deposits in northwestern Nevada. Furthermore, Integra Resources maintains a portfolio of early-stage exploration projects across Idaho, Nevada, and Arizona.
Knight Therapeutics
Post in 2016
Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of innovative prescription pharmaceuticals, consumer health products, and medical devices. The company offers a range of commercialized products, including Movantik for opioid-induced constipation, Mytesi for noninfectious diarrhea in adults with HIV or AIDS, NERLYNX for HER2-positive breast cancer, and Trelstar for prostate cancer. Additionally, Knight Therapeutics is involved in the development of treatments for conditions such as opioid addiction, chronic pain, diabetes-related eye diseases, and neurological disorders. Their product pipeline includes various therapies targeting acute migraine, HPV-associated cancers, and osteoarthritis-related pain, among others. Founded in 2013, Knight Therapeutics continues to expand its portfolio and invest in innovative life sciences solutions both in Canada and internationally.
Knight Therapeutics
Post in 2016
Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of innovative prescription pharmaceuticals, consumer health products, and medical devices. The company offers a range of commercialized products, including Movantik for opioid-induced constipation, Mytesi for noninfectious diarrhea in adults with HIV or AIDS, NERLYNX for HER2-positive breast cancer, and Trelstar for prostate cancer. Additionally, Knight Therapeutics is involved in the development of treatments for conditions such as opioid addiction, chronic pain, diabetes-related eye diseases, and neurological disorders. Their product pipeline includes various therapies targeting acute migraine, HPV-associated cancers, and osteoarthritis-related pain, among others. Founded in 2013, Knight Therapeutics continues to expand its portfolio and invest in innovative life sciences solutions both in Canada and internationally.
Integra Gold is a company that specializes in gold exploration services, focusing on projects and mining operations in Val-d'Or, Québec, a prominent mining region. The company provides a variety of services aimed at facilitating gold exploration, allowing clients to access potential drilling opportunities in this well-regarded jurisdiction. Through its offerings, Integra Gold aims to support the development and advancement of gold mining projects.
Integra Gold is a company that specializes in gold exploration services, focusing on projects and mining operations in Val-d'Or, Québec, a prominent mining region. The company provides a variety of services aimed at facilitating gold exploration, allowing clients to access potential drilling opportunities in this well-regarded jurisdiction. Through its offerings, Integra Gold aims to support the development and advancement of gold mining projects.
Integra Gold is a company that specializes in gold exploration services, focusing on projects and mining operations in Val-d'Or, Québec, a prominent mining region. The company provides a variety of services aimed at facilitating gold exploration, allowing clients to access potential drilling opportunities in this well-regarded jurisdiction. Through its offerings, Integra Gold aims to support the development and advancement of gold mining projects.
Knight Therapeutics
Post in 2014
Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of innovative prescription pharmaceuticals, consumer health products, and medical devices. The company offers a range of commercialized products, including Movantik for opioid-induced constipation, Mytesi for noninfectious diarrhea in adults with HIV or AIDS, NERLYNX for HER2-positive breast cancer, and Trelstar for prostate cancer. Additionally, Knight Therapeutics is involved in the development of treatments for conditions such as opioid addiction, chronic pain, diabetes-related eye diseases, and neurological disorders. Their product pipeline includes various therapies targeting acute migraine, HPV-associated cancers, and osteoarthritis-related pain, among others. Founded in 2013, Knight Therapeutics continues to expand its portfolio and invest in innovative life sciences solutions both in Canada and internationally.
Knight Therapeutics
Post in 2014
Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of innovative prescription pharmaceuticals, consumer health products, and medical devices. The company offers a range of commercialized products, including Movantik for opioid-induced constipation, Mytesi for noninfectious diarrhea in adults with HIV or AIDS, NERLYNX for HER2-positive breast cancer, and Trelstar for prostate cancer. Additionally, Knight Therapeutics is involved in the development of treatments for conditions such as opioid addiction, chronic pain, diabetes-related eye diseases, and neurological disorders. Their product pipeline includes various therapies targeting acute migraine, HPV-associated cancers, and osteoarthritis-related pain, among others. Founded in 2013, Knight Therapeutics continues to expand its portfolio and invest in innovative life sciences solutions both in Canada and internationally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.